Sabin CA, Lepri A, Phillips AN
Researching an off-ramp Clinicians have a body of research on starting GLP-1s, but theres less evidence on how to stop them, Biermann says
Instead, it reveals genetic predispositions that historically correlate with differential weight loss, glycemic control, and appetite response patterns across GLP-1 agonists
Ethics This case report was conducted in accordance with the ethical standards of the institutional research committee at the University of Virginia
Some medications are approved for other conditions but also help manage weight
Currently, several FDA-approved GLP-1 medications are available for weight management , including semaglutide (marketed as Wegovy for weight loss and Ozempic for diabetes) and tirzepatide (Mounjaro and Zepbound)